NCT06151132

Brief Summary

Description of treatment of cardiovascular diseases in community settings in Russia

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
430

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 30, 2023

Completed
Last Updated

November 30, 2023

Status Verified

November 1, 2023

Enrollment Period

6.9 years

First QC Date

November 21, 2023

Last Update Submit

November 21, 2023

Conditions

Atrial ArrhythmiaCardiovascular Diseases

Outcome Measures

Primary Outcomes (2)

  • Restoration of sinus rhythm

    Restoration of sinus rhythm during direct current cardioversion

    1 day

  • Maintenance in rhythm control strategy

    Maintenance in rhythm control strategy during treatment of atrial fibrillation

    7 years

Other Outcomes (14)

  • Gender

    During procedure

  • Age

    During procedure

  • Body mass index

    During procedure

  • +11 more other outcomes

Study Arms (1)

Patients with atrial fibrillation

Direct current cardioversion

Procedure: Direct current cardioversion

Interventions

Direct current cardioversionPROCEDURE

Direct current cardioversion to maintain sinus rhythm during rhythm control strategy

Patients with atrial fibrillation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People receiving treatment for atrial fibrillation in Tarusa hospital.

You may qualify if:

  • all patients undergoing direct current cardioversion for atrial fibrillation or flutter

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

Electric Countershock

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeutics

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
researcher in Digital Public Health Technologies

Study Record Dates

First Submitted

November 21, 2023

First Posted

November 30, 2023

Study Start

January 1, 2016

Primary Completion

December 1, 2022

Study Completion

March 1, 2023

Last Updated

November 30, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will share

Deposition of all anonymized data in public repository.

Shared Documents
ANALYTIC CODE
Time Frame
With the publication, for 5 years.
Access Criteria
Public domain.